tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Stock WebsitesTop Gainers/ Losers/ Active StocksDividend StocksChatGPT Stocks
ETFs
ETF CenterTop ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Crypto CenterBitcoin
Popular
Ethereum
Research Tools
Stock ScreenerETF Screener
Popular
Compare StocksCompare ETFsTrending StocksTechnical Analysis ScreenerPenny Stock ScreenerDaily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit CalculatorCompound Interest Calculator
New
Mortgage Calculator
New
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compound Interest Calculator
New
Mortgage Calculator
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Enterprise Solutions
Plans & Pricing
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALRN Stock Latest News

ALRN Upcoming Earnings Report: What to Expect?
Pre-EarningsALRN Upcoming Earnings Report: What to Expect?
5M ago
ALRN
Aileron Therapeutics (ALRN) Q4 Earnings Cheat Sheet
Pre-EarningsAileron Therapeutics (ALRN) Q4 Earnings Cheat Sheet
6M ago
ALRN
Aileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
Press ReleasesAileron Therapeutics Announces Termination of Phase 1b Breast Cancer Chemoprotection Trial and Exploration of Strategic Alternatives
7M ago
ALRN
Aileron Therapeutics to reduce workforce from nine to three full-time employees
The FlyAileron Therapeutics to reduce workforce from nine to three full-time employees
7M ago
ALRN
Aileron Therapeutics announces exploration of strategic alternatives
The FlyAileron Therapeutics announces exploration of strategic alternatives
7M ago
ALRN
Aileron Therapeutics terminates Phase 1b breas cancer chemoprotection trial
The FlyAileron Therapeutics terminates Phase 1b breas cancer chemoprotection trial
7M ago
ALRN
Aileron Therapeutics regains compliance with Nasdaq listing requirements
The FlyAileron Therapeutics regains compliance with Nasdaq listing requirements
10M ago
ALRN
Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements
Press ReleasesAileron Therapeutics Regains Compliance with Nasdaq Listing Requirements
10M ago
ALRN
Aileron Therapeutics announces 1-for-20 reverse stock split
The FlyAileron Therapeutics announces 1-for-20 reverse stock split
11M ago
ALRN
Aileron Therapeutics Announces a 1-for-20 Reverse Stock Split
Press ReleasesAileron Therapeutics Announces a 1-for-20 Reverse Stock Split
11M ago
ALRN
Aileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
Press ReleasesAileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
11M ago
ALRN
Aileron Therapeutics Presents Results from Phase 1 Study in Healthy Volunteers Demonstrating ALRN-6924 Induced Cell Cycle Arrest in Bone Marrow Stem Cells and Hair Follicles at EORTC-NCI-AACR International Conference
Press ReleasesAileron Therapeutics Presents Results from Phase 1 Study in Healthy Volunteers Demonstrating ALRN-6924 Induced Cell Cycle Arrest in Bone Marrow Stem Cells and Hair Follicles at EORTC-NCI-AACR International Conference
11M ago
ALRN
Aileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at the European Society for Dermatological Research Annual Meeting 2022
Press ReleasesAileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at the European Society for Dermatological Research Annual Meeting 2022
12M ago
ALRN
Aileron Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Press ReleasesAileron Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
1y ago
ALRN
Aileron Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
Press ReleasesAileron Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
1y ago
ALRN
Aileron Therapeutics Is Pleased to Outline Strategy to Strengthen Phase 1b Clinical Trial of ALRN-6924 in Patients with p53-Mutated Breast Cancer
Press ReleasesAileron Therapeutics Is Pleased to Outline Strategy to Strengthen Phase 1b Clinical Trial of ALRN-6924 in Patients with p53-Mutated Breast Cancer
1y ago
ALRN
Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2022
Press ReleasesAileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2022
1y ago
ALRN
Aileron Therapeutics Announces Interim Data from Phase 1b Chemoprotection Trial of ALRN-6924 in Patients with p53-Mutated Non-Small Cell Lung Cancer (NSCLC) and Confirms Development Path for ALRN-6924 Focused on p53-Mutated Breast Cancer
Press ReleasesAileron Therapeutics Announces Interim Data from Phase 1b Chemoprotection Trial of ALRN-6924 in Patients with p53-Mutated Non-Small Cell Lung Cancer (NSCLC) and Confirms Development Path for ALRN-6924 Focused on p53-Mutated Breast Cancer
1y ago
ALRN
Medicenna vs Aileron: Which Penny Stock Could Surge Over 200%?
Market NewsMedicenna vs Aileron: Which Penny Stock Could Surge Over 200%?
3y ago
ALRN
3 “Strong Buy” Penny Stocks That Could Go Boom
Stock Analysis & Ideas3 “Strong Buy” Penny Stocks That Could Go Boom
3y ago
ALRN
CRIS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >